InvestorsHub Logo
Followers 50
Posts 9062
Boards Moderated 1
Alias Born 01/13/2007

Re: HANUMAN post# 1558

Wednesday, 02/03/2021 2:21:14 PM

Wednesday, February 03, 2021 2:21:14 PM

Post# of 3635
It seemingly would make sense to raise cash at these levels so I bowed out yesterday and left some money on the table here but I own several of these and in the long run AD is tough to tame. For whatever anavex has on the positive side, IMO AD isn't one of them. I'm still waiting on the top line data from their PDD trial that I thought was to come out last summer. Regardless they have made a strong move, same with others making funding easier, and maybe Rett or orphan diseases will be their ticket. I truly do not know but would love to see it. I'm currently more interested in AD to be honest and at this point SAVA and SNPX are the only two I know of who have actually reversed and increased test scores in any populations.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SAVA News